Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.36 |
| ▸ | JAK2 | O60674 | 2/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.34 |
| ▸ | PRKCA | P17252 | 2/20 | 0.34 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.34 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.34 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.34 |
| ▸ | PRKACA | P17612 | 1/20 | 0.34 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | JAK3 | P52333 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | BLM | P54132 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29650409 | 0.80 | SMN1; SMN2 (0.48) | SMN1; SMN2L3MBTL1CHRM2JAK2ROCK2 | |
| SCHEMBL1238391 | 0.80 | SMN1; SMN2 (0.48) | SMN1; SMN2L3MBTL1CHRM2JAK2ROCK2 | |
| SCHEMBL13342069 | 0.77 | SMN1; SMN2 (0.54) | SMN1; SMN2L3MBTL1KDM4EALDH1A1BLM | |
| SCHEMBL2068478 | 0.77 | SMN1; SMN2 (0.55) | SMN1; SMN2L3MBTL1CHRM2KDM4EALDH1A1 | |
| Acetonitrile SCHEMBL2818707 | 0.76 | SMN1; SMN2 (0.48) | SMN1; SMN2L3MBTL1CHRM2KDM4EALDH1A1 | |
| SCHEMBL15693459 | 0.76 | SMN1; SMN2 (0.44) | SMN1; SMN2L3MBTL1CHRM2PRKCQJAK3 | |
| SCHEMBL18567270 | 0.74 | SMN1; SMN2 (0.42) | SMN1; SMN2L3MBTL1CHRM2KDM4EALDH1A1 | |
| SCHEMBL11629381 | 0.74 | CHRM2 (0.44) | SMN1; SMN2L3MBTL1CHRM2KDM4EALDH1A1 | |
| SCHEMBL7474039 | 0.74 | SMN1; SMN2 (0.50) | SMN1; SMN2L3MBTL1CHRM2KDM4EALDH1A1 | |
| SCHEMBL12040028 | 0.73 | SMN1; SMN2 (0.54) | SMN1; SMN2L3MBTL1CHRM2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773090-B2 | Pharmaceutical compounds | HEPTARES THERAPEUTICS LIMITED (GB) | 2023-10-03 | — | — | US | disclosed |
| US-20210002271-A1 | PHARMACEUTICAL COMPOUNDS | NXERA PHARMA UK LIMITED (GB) | 2021-01-07 | — | — | US | disclosed |
| US-10787447-B2 | Pharmaceutical compounds | HEPTARES THERAPEUTICS LIMITED (GB) | 2020-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773090-B2 | Pharmaceutical compounds | CHRM1, CHRM2, CHRM4 | SMN1; SMN2 2514/4885L3MBTL1 3557/4885CHRM2 2/4885 |
| US-20210002271-A1 | PHARMACEUTICAL COMPOUNDS | CHRM1, CHRM2, CHRM4 | SMN1; SMN2 2514/4885L3MBTL1 3557/4885CHRM2 2/4885 |
| US-10787447-B2 | Pharmaceutical compounds | CHRM1, CHRM2, CHRM4 | SMN1; SMN2 2514/4885L3MBTL1 3557/4885CHRM2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.